This webinar explores the role of artificial intelligence (AI) and computer vision for diseases in the foregut. It also serves as a brief primer for gastroenterologists who are new to AI, with a discussion on how AI will impact the clinical practice of GI in the future.

Learning objectives:

During the first part of the webinar, our experts will discuss:

• Common terms associated with AI and computer vision
• How computer vision algorithms are created and the regulatory pathway
• The current focus for AI work for foregut diseases
• How AI will impact clinical practice in GI
  

Following the initial discussion, enjoy a pre-recorded presentation sponsored by Castle Biosciences. This discussion will focus on managing Barrett's esophagus, which involves a multi-step process from screening and surveillance to eradication treatment. A key challenge is determining which patients should be surveilled and at what intervals and identifying those who require more aggressive eradication strategies. Currently, management relies on histological diagnosis and specific clinical factors; however, there has been little improvement in the incidence and mortality rates of esophageal adenocarcinoma (EAC) over the past few decades, highlighting the need for better risk stratification. The presentation will explore the TissueCypher assay, an AI-driven prognostic tool for Barrett's patients diagnosed with NDBE, IND, or LGD. This assay provides a personalized, independent 5-year risk assessment for progression to high-grade dysplasia (HGD) or EAC.

During this presentation, get details about:

• The limitations in current Barrett’s esophagus risk stratification
• The components of an AI-derived spatialomics prognostic assay for Barrett’s Esophagus (TissueCypher)
• The clinical validity and impact of clinical decision-making of TissueCypher on personalized risk stratification

Speakers:

Jason B. Samarasena, MD, MBA, AGAF
Professor of Medicine
Associate Chief - Division of Gastroenterology and Hepatology 
Director – Interventional Endoscopy Training Program
Division of Gastroenterology and Hepatology – Interventional Endoscopy
H. H. Chao Digestive Health Institute
University of California Irvine

Michael Byrne, MD
Clinical Professor of Medicine
Vancouver General Hospital
University of British Columbia

Presenter:
Michael S. Smith, MD, MBA
Associate Chief of Gastroenterology
Mount Sinai Health System

 

 

Pricing:

Member	Nonmember
Free	Free